Hemant Malhotra
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Co-authors
- Hagop M. Kantarjian (3 shared papers)Dong‐Wook Kim (2 shared papers)Karı̈n Gogat (2 shared papers)Jörge E. Cortes (2 shared papers)Carlo Gambacorti‐Passerini (2 shared papers)Laimonas Griškevičius (2 shared papers)Tim H. Brümmendorf (2 shared papers)Iryna Dyagil (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (3 papers)Blood (3 papers)ESMO Open (2 papers)JCO Global Oncology (2 papers)
- Partner nations
- IndiaUnited StatesGermany
In The Last Decade
Hemant Malhotra
63 papers receiving 938 citations
Hemant Malhotra's Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 430
- Genetics 377
- Rheumatology 200
- Oncology 239
- Internal Medicine 20
Countries citing papers authored by Hemant Malhotra
This map shows the geographic impact of Hemant Malhotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant Malhotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant Malhotra more than expected).
Fields of papers citing papers by Hemant Malhotra
This network shows the impact of papers produced by Hemant Malhotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant Malhotra. The network helps show where Hemant Malhotra may publish in the future.
Co-authors
The 25 scholars most cited alongside Hemant Malhotra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial Hit paper breakdown → | 2012 | 344 |
| 2 | 2009 | 47 | |
| 3 | 1985 | 47 | |
| 4 | 2019 | 41 | |
| 5 | 2000 | 32 | |
| 6 | 2010 | 31 | |
| 7 | Gonadal function in prepubertal boys following treatment for Hodgkin's disease. | 1993 | 30 |
| 8 | 2011 | 24 | |
| 9 | 2009 | 23 | |
| 10 | 2014 | 22 | |
| 11 | 2015 | 19 | |
| 12 | 2014 | 19 | |
| 13 | 2019 | 18 | |
| 14 | 2009 | 17 | |
| 15 | 2021 | 17 | |
| 16 | 2014 | 17 | |
| 17 | 1991 | 16 | |
| 18 | 2020 | 15 | |
| 19 | 2017 | 15 | |
| 20 | 2011 | 15 |
About Hemant Malhotra
Hemant Malhotra is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Hematology and Surgery, having authored 72 papers that have together received 973 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (12 papers), Eosinophilic Disorders and Syndromes (7 papers), Lung Cancer Treatments and Mutations (6 papers), Head and Neck Cancer Studies (5 papers), Economic and Financial Impacts of Cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (430 citations), Genetics (377 citations), Rheumatology (200 citations), Oncology (239 citations) and Internal Medicine (20 citations). Hemant Malhotra has collaborated with scholars based in India, United States and Germany. Frequent co-authors include Hagop M. Kantarjian, Dong‐Wook Kim, Karı̈n Gogat, Jörge E. Cortes, Carlo Gambacorti‐Passerini, Laimonas Griškevičius, Tim H. Brümmendorf, Iryna Dyagil, Athena Countouriotis and Christine Powell. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, ESMO Open and JCO Global Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.